Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

D.I.Y. genome-wide association

Discover how to validate phenotype amidst logistic issues and the challenge of identifying small effect loci in disease phenotypes.

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

Saw this on Twitter, but I've talked to others who have brought up this issue:

It seems the logistic issues are the big problem. How do you validate phenotype? Tight-knit communities could probably work just based on trust, but then how do you scale up the sample size to detect loci of small effect? I think it will come, but I'm not sure when. Though obviously when it comes to disease phenotypes there's going to be more motivation by interested parties. In the near future we'll have pretty cheap full sequences, so one could probe differences within families to pick out possible mutations which might account for the variance you see across siblings. But would people really want to know why they're smarter/stupider or better looking/uglier than their brother/sister? Isn't the reality enough?

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles